Try our beta test site

The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by East Suburban Ob Gyn.
Recruitment status was:  Recruiting
West Penn Allegheny Health System
Information provided by (Responsible Party):
Michael Pelekanos MD, East Suburban Ob Gyn Identifier:
First received: March 1, 2010
Last updated: March 1, 2012
Last verified: March 2012
The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Female Sexual Dysfunction

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire

Further study details as provided by East Suburban Ob Gyn:

Estimated Enrollment: 200
Study Start Date: March 2010
Estimated Study Completion Date: July 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Detailed Description:
To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Ages Eligible for Study:   25 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent

Inclusion Criteria:

  • Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

  • Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01078077

United States, Pennsylvania
East Suburban Obgyn
Monroeville, Pennsylvania, United States, 15146
West Penn Allegheny Health Center
Monroeville, Pennsylvania, United States, 15146
West Penn Hospital Forbes Campus
Monroeville, Pennsylvania, United States, 15146
Sponsors and Collaborators
Michael Pelekanos MD
West Penn Allegheny Health System
Principal Investigator: michael j pelekanos, MD east surburban obgyn
  More Information

Responsible Party: Michael Pelekanos MD, michael pelekanos MD, WPAHS, East Suburban Ob Gyn Identifier: NCT01078077     History of Changes
Other Study ID Numbers: 10-005 
Study First Received: March 1, 2010
Last Updated: March 1, 2012

Keywords provided by East Suburban Ob Gyn:
healthy females ages twentyfive through sixty processed this record on February 20, 2017